marijuana stocks news

Form 8-K for ENERTOPIA CORP.


19-Sep-2016

Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial State

Item 3.02 Unregistered Sales of Equity SecuritiesOn September 19, 2016, the Company entered into a one year Investor Relations Consulting agreement with Duncan McKay. Based on the terms of the agreement, Mr. McKay can earn up to a maximum of 10% commissions on capital raised. The Company issued 800,000 stock options with an exercise price of $0.07.

The Company issued 800,000 stock options. On July 15, 2014, the Company had adopted the 2014 Stock Option Plan. Based on this original Stock Option Plan, on September 19, 2016, the Company has granted 80,000 stock options to Duncan McKay. The exercise price of the stock options is $0.07, vested immediately, expiring September 19, 2021.

Name and Position Amount of stock options grant Duncan McKay 800,000

 

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the agreement and options grant is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No.                             Description

   10.1       Form of Stock Option Agreement
   10.2       Investor Relations Consulting Agreement dated September 19, 2016
   99.1       Press Release dated September 19, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$GBLX Will Collaborate on App for Cannabis Patient Care and Commerce

GB Sciences and MJ Freeway Collaborate on Cannabis Patient Care and Commerce…

AgraFlora Organics International Inc. (AGRA) (AGFAF) Enters Into Preferred Supply Agreement

AgraFlora Organics Enters Into Preferred Supply Agreement with Distributor to Loblaws and…

$NTRR Federal Court Ruling Achieves Milestone

NTRR: Federal Court Ruling Achieves Milestone in North America’s Second-Largest Medical Cannabis…

$INSY Receives FDA Orphan Drug Designation

  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol…